Biomedical Engineering Reference
In-Depth Information
Sacks, F.M. and P. Alaupovic, L.A. Moye, T.G. Cole, B. Sussex, M.J. Stampfer, M.A. Pfef er,
and E. Braunwald. 2000. VLDL, apolipoproteins B, CIII, and E, and risk of recurrent
coronary events in the Cholesterol and Recurrent Events (CARE) trial. Circulation 102:
1886-1892.
Sotiriou, S.N.
et al.
2006. Lipoprotein(a) in atherosclerotic plaques recruits inl ammatory
cells through interaction with Mac-1 integrin. FASEB J. 20: 559-561.
Stannard, A.K. and D.R. Riddell, S.M. Sacre, A.D. Tagalakis, C. Langer, A. von Eckardstein, P.
Cullen, T. Athanasopoulos, G. Dickson, and J.S. Owen. 2001. Cell-derived apolipoprotein
E (ApoE) particles inhibit vascular cell adhesion molecule-1 (VCAM-1) expression in
human endothelial cells. J. Biol. Chem. 276: 46011-46016.
Sundaram, M. and P. Links, M.B. Khalil, Y. Wang, S. Zhong, and Z. Yao. 2007. New insights
into the roles of apolipoprotein C-III in stimulating the production of hepatic VLDL.
Arterioscler. h romb. Vasc. Biol. Annu. Conf. P142.
Takami, S. and S. Yamashita, S. Kihara, M. Ishigami, K. Takemura, N. Kume, T. Kita, and
Y. Matsuzawa. 1998. Lipoprotein(a) enhances the expression of intercellular adhesion
molecule-1 in cultured human umbilical vein endothelial cells. Circulation 97: 721-
728.
Tsurumi, Y and H. Nagashima, K. Ichikawa, T. Sumiyoshi, and S. Hosoda. 1995. Inl uence
of plasma lipoprotein (a) levels on coronary vasomotor response to acetylcholine. J. Am.
Coll. Cardiol. 26: 1242-1250.
Zheng, C and C. Khoo, K. Ikewaki, and F.M. Sacks. 2007. Rapid turnover of apolipoprotein
C-III-containing triglyceride-rich lipoproteins contributing to the formation of LDL
subfractions. J. Lipid Res. 48: 1190-1203.
